SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Directorate Change

20 Oct 2014 07:00

ELEMENTIS PLC - Directorate Change

ELEMENTIS PLC - Directorate Change

PR Newswire

London, October 19

20 October 2014 Elementis - Directorate Changes Elementis plc (ELM.L) (the "Company"), the FTSE 250 Global Specialty ChemicalsCompany, today announces the following changes to its Board of Directors: Board appointments * Nick Salmon to be appointed a non-executive Director and a member of the Audit, Nomination and Remuneration Committees with effect from 20 October 2014 and Senior Independent Director with effect from 16 December 2014. * Steve Good to be appointed a non-executive Director and a member of the Audit, Nomination and Remuneration Committees with effect from 20 October 2014. Board retirements * Ian Brindle, who is Senior Independent Director and a member of the Audit and Nomination Committees, will be retiring from those roles and as a non-executive Director of the Company with effect from 15 December 2014. * Kevin Matthews, who is a member of the Audit, Nomination and Remuneration Committees, will be retiring from those roles and as a non-executive Director of the Company with effect from 31 October 2014. Nick Salmon, 62, has been a non-executive Director of Interserve plc sinceAugust 2014. He was a non-executive Director of United Utilities Group plcbetween April 2005 and July 2014, where he was also the Senior IndependentDirector between 2007 and 2014. He was Chief Executive of Cookson Group plcfrom July 2004 to December 2012 when Cookson demerged to create two new listedcompanies, Vesuvius plc and the specialty chemicals company, Alent plc. He wasformerly Executive Vice-President of Alstom S.A. and Chief Executive of BabcockInternational Group plc. He held other senior management positions that includeat GEC and GEC Alsthom in the UK and France and the China Light and PowerCompany, Hong Kong. Nick holds a BSc. Degree in Mechanical Engineering and is aFellow of the Royal Academy of Engineering. Steve Good, 53, has been a non-executive Director of Zotefoams plc since 1October 2014. He was Chief Executive of Low & Bonar PLC between September 2009and September 2014. Prior to that role, he was Managing Director of itsTechnical Textiles division between 2006 and 2009, Director of New Businessbetween 2005 and 2006, and Managing Director of its Plastics Division between2004 and 2005. Prior to joining Low & Bonar he spent 10 years with BTP plc (nowpart of Clariant) in a variety of leadership positions managing internationalspeciality chemicals businesses. He is a chartered accountant. Commenting on the Board changes Andrew Duff, Chairman of Elementis, said: "Onbehalf of the Board, I am delighted that Nick and Steve have agreed to join theElementis Board. We are very pleased to attract two high-calibre and provenindividuals to add to the depth and strength of the skill set in our boardroom. Nick is an experienced Senior Independent Director who is well regarded in theCity both as a non-executive and as an accomplished executive. His businessinsights and experience, particularly of growing a mid-cap company with aninternational manufacturing presence both organically and through acquisitions,will help build on the solid foundations at Elementis as we seek to deliversuperior, sustainable returns from our growth strategy. Steve brings a fresh perspective in terms of his experience of and broadinternational exposure to specialty chemicals businesses, manufacturing anddiverse industrial markets. He has a strong track record of acquiring newbusinesses, integrating them successfully and driving organic growth through afocus on innovation. His skills and knowledge will be of great benefit asElementis progresses through the next stage of its development. I welcome both Nick and Steve and look forward to working with them over thecoming years to transform Elementis into a larger and more successful globalspecialty chemicals company. Turning to our retiring Directors, on behalf of the Board, I would like tothank and express appreciation to Ian Brindle and Kevin Matthews for theircommitment and significant contribution to the Elementis growth story over aperiod of more than 9 years. Ian's advice and support to me personally has been invaluable and his overallsupport and counsel to the Board and executive management is much appreciated.His financial acumen, thoughtful engaging manner and sense of humour have allcontributed greatly to the performance, cohesion and effectiveness of theBoard. Kevin's background in chemistry, experience of commercialising technology andhis interest in operations and manufacturing have enabled him to make avaluable contribution in the Elementis boardroom. We wish them both well in their future endeavours." The Company confirms that there are no other matters requiring disclosure inrelation to listing rule 9.6.13 in respect of either Board appointment. Wai WongCompany Secretary020 7408 9300
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.